Skip to main content

Table 1 The establishment of subcutaneous cervical cancer—PDX* models

From: Establishment and genetically characterization of patient-derived xenograft models of cervical cancer

PDX models

Failure (%)

Success (%)

Latency time (days)#

Mortalitya (%)

F1 engraftment results

63 (69.23)

28 (30.77)

87.00 (77.25,104.00)

6 (21.43)

F2 engraftment results

17 (31.48)

37 (68.52)

48.00 (40.00,60.50)

5 (13.51)

F3 engraftment results

7 (12.07)

51 (87.93)

38.00 (29.00,46.00)

5 (9.80)

  1. Data are presented as n (%) or median (P25, P75)
  2. *Patient - derived xenograft (PDX)
  3. #The time interval from engraftment to the presence of palpable tumor was defined as the latency time
  4. aThe mortality of mice among the successful cervical cancer engrafted mice
Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us